This study provides innovative insights into the inhibitory role of SLC7A2 in LNM of HNSCC and suggests a mechanism by which it may impede lymphangiogenesis through the modulation of CPB2 activity. The gene discussed is CPB2; the disease is head and neck squamous cell carcinoma.